Phase 3 Polycystic Ovary Syndrome Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome
Polycystic Ovary SyndromeReproductive Medicine
University Hospital, Lille276 enrolled1 locationNCT03059173
Recruiting
Phase 3
Role of Semaglutide in Restoring Ovulation in Youth and Adults With Polycystic Ovary Syndrome
ObesePCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
University of Colorado, Denver80 enrolled1 locationNCT05819853
Recruiting
Phase 3
The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients
Polycystic Ovary Syndrome
Cairo University102 enrolled1 locationNCT06836128
Recruiting
Phase 2Phase 3
Semaglutide in Women With Polycystic Ovary Syndrome and Obesity
ObesityPolycystic Ovary Syndrome (PCOS) Women
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh30 enrolled1 locationNCT06896981
Recruiting
Phase 3
Effect of ALA Combined With Letrozole on Polycystic Ovary Syndrome Clinical Outcome in Infertile Females
Polycystic Ovary SyndromeInfertility, Female
Ain Shams University150 enrolled2 locationsNCT06418347
Recruiting
Phase 3
Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome
Polycystic Ovary Syndrome
Future University in Egypt70 enrolled1 locationNCT06576375